Thousand Oaks, California
United States
49
2025-12-18
The entities that hold a legal rights for patent applications filed by inventor Liu Longbin:
Longbin Liu from Thousand Oaks, US has applied for patents for these inventions. The list has both pending applications and granted patents:
KRAS G12C INHIBITORS AND METHODS OF USING THE SAME
#2 | 2024-10-17HETEROCYCLIC COMPOUNDS AND IMAGING AGENTS FOR IMAGING HUNTINGTIN PROTEIN
#3 | 2024-05-30KRAS G12C INHIBITORS AND METHODS OF USING THE SAME
#4 | 2024-02-15KRAS G12C INHIBITORS AND METHODS OF USING THE SAME
#5 | 2023-05-25HTT modulators for treating Huntington's disease
#6 | 2022-12-29HTT modulators for treating Huntington's disease
#7 | 2022-12-15KRAS G12C inhibitors and methods of using the same
#8 | 2022-11-24DEUTERATED COMPOUNDS AND IMAGING AGENTS FOR IMAGING HUNTINGTIN PROTEIN
#9 | 2022-10-27ISOINDOLINONE COMPOUNDS AND IMAGING AGENTS FOR IMAGING HUNTINGTIN PROTEIN
#10 | 2022-06-09Substituted piperazines as KRAS G12C inhibitors
#11 | 2022-02-10Heterobiaryl compounds and imaging agents for imaging huntingtin protein
#12 | 2022-01-06KRAS G12C INHIBITORS AND METHODS OF USING THE SAME
#13 | 2021-12-23Heterocyclic compounds and imaging agents for imaging huntingtin protein
#14 | 2021-08-05Compounds and probes for imaging huntingtin protein
#15 | 2021-01-14KRAS G12C inhibitors and methods of using the same
#16 | 2020-07-231,4-thiazine dioxide and 1,2,4-thiadiazine dioxide derivatives as beta-secretase inhibitors and methods of use
#17 | 2020-02-20KRAS G12C INHIBITORS AND METHODS OF USING THE SAME
#18 | 2019-12-12KRAS G12C INHIBITORS AND METHODS OF USING THE SAME
#19 | 2019-12-12Substituted piperazines as KRAS G12C inhibitors
#20 | 2019-11-14KRAS G12C inhibitors and methods of using the same
#21 | 2018-11-22KRAS G12C inhibitors and methods of using the same
#22 | 2018-08-09Vinyl fluoride cyclopropyl fused thiazin-2-amine compounds as beta-secretase inhibitors and methods of use
#23 | 2017-09-21CYCLOPROPYL FUSED THIAZIN-2-AMINE COMPOUNDS AS BETA-SECRETASE INHIBITORS AND METHODS OF USE
#24 | 2016-02-18Cyclopropyl fused thiazin-2-amine compounds as beta-secretase inhibitors and methods of use
#25 | 2013-11-14Fused heterocyclic derivatives and methods of use
#26 | 2013-03-28Inhibitors of PI3 kinase and/or mTOR
#27 | 2012-09-06Compounds that interact with glucokinase regulatory protein for the treatment of diabetes
#28 | 2012-06-14Fused heterocyclic derivatives and methods of use
#29 | 2012-05-03FUSED HETEROCYCLIC DERIVATIVES AND METHODS OF USE
#30 | 2012-03-22Inhibitors of PI3 kinase
#31 | 2012-03-22Method of treating cancer with substituted amide derivatives
#32 | 2011-05-19Substituted amide derivatives and methods of use
#33 | 2011-04-21Inhibitors of PI3 kinase
#34 | 2010-10-28Inhibitors of PI3 kinase and/or mTOR
#35 | 2009-12-24Fused heterocyclic derivatives and methods of use
#36 | 2009-06-25Imidazopyridazine inhibitors of PI3 kinase for cancer treatment
#37 | 2009-05-14Fused heterocyclic derivatives and methods of use
#38 | 2009-05-14Fused heterocyclic derivatives and methods of use
#39 | 2009-02-26Benzothiazole PI3 kinase modulators for cancer treatment
#40 | 2008-12-18Substituted amide derivatives and methods of use
#41 | 2008-11-13Nitrogen-containing heterocyclyl ketones and methods of use
#42 | 2007-03-08Bis-aryl kinase inhibitors and method
#43 | 2006-11-09Substituted heterocycles and methods of use
#44 | 2006-03-30Substituted heterocyclic compounds and methods of use
#45 | 2005-12-29Substituted heterocyclic compounds and methods of use
#46 | 2005-08-25Substituted heterocyclic compounds and methods of use
#47 | 2005-02-24Substituted heterocyclic compounds and methods of use
#48 | 2005-02-01Integrin inhibitors and their methods of use
#49 | 2005-01-27Substituted heterocyclic compounds and methods of use
167282 ⎘